COVID-19, acute myocardial injury, and infarction
A Del Prete, F Conway… - Cardiac …, 2022 - cardiacep.theclinics.com
The new coronavirus-associated disease 2019 (COVID-19), due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents an unprecedented public health …
syndrome coronavirus-2 (SARS-CoV-2), represents an unprecedented public health …
[HTML][HTML] The dual pandemics of COVID-19 and obesity: bidirectional impact
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the
COVID-19 pandemic, has been shown to disrupt many organ systems in the human body …
COVID-19 pandemic, has been shown to disrupt many organ systems in the human body …
[HTML][HTML] Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Rationale About 50% of hospitalized coronavirus disease 2019 (COVID-19) patients with
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction
Objective The initial data of the International Study on Acute Coronary Syndromes-ST
Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction in …
Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction in …
[HTML][HTML] The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
L Czupryniak, D Dicker, R Lehmann, M Prázný… - Cardiovascular …, 2021 - Springer
Patients with Covid-19 place new challenges on the management of type 2 diabetes,
including the questions of whether glucose-lowering therapy should be adjusted during …
including the questions of whether glucose-lowering therapy should be adjusted during …
Impact of the COVID‐19 Pandemic on Diabetes‐Related Cardiovascular Mortality in the United States
Background In the past few decades, diabetes‐related cardiovascular mortality has been
steadily declining. However, the impact of the COVID19 pandemic on this trend has not …
steadily declining. However, the impact of the COVID19 pandemic on this trend has not …
[HTML][HTML] Острый коронарный синдром у пациентов с COVID-19
МГ Чащин, АЮ Горшков… - … терапия и профилактика, 2021 - cyberleninka.ru
Развитие острого коронарного синдрома (ОКС) обусловлено острым несоответствием
потребности миокарда в кислороде и его доставкой. Данный механизм в большей мере …
потребности миокарда в кислороде и его доставкой. Данный механизм в большей мере …
[HTML][HTML] Effect of Ticagrelor compared to Clopidogrel on short-term outcomes of COVID-19 patients with acute coronary syndrome undergoing percutaneous coronary …
R Arefizadeh, SH Moosavi, S Towfiqie… - Archives of Academic …, 2023 - ncbi.nlm.nih.gov
Methods: In this multicenter clinical trial, 180 COVID-19 patients with ACS who underwent
urgent percutaneous coronary intervention (PCI) were randomized to receive Ticagrelor …
urgent percutaneous coronary intervention (PCI) were randomized to receive Ticagrelor …
[HTML][HTML] Cardiometabolic alterations in the interplay of COVID-19 and diabetes: current knowledge and future avenues
IJMS | Free Full-Text | Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes:
Current Knowledge and Future Avenues Next Article in Journal Incretins in the Therapy of …
Current Knowledge and Future Avenues Next Article in Journal Incretins in the Therapy of …
[HTML][HTML] Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020
BG Alekyan, SA Boytsov, EM Manoshkina… - Kardiologiia, 2021 - lib.ossn.ru
Aim To analyze the number of cases of acute coronary syndrome (ACS)[ST segment
elevation myocardial infarction (STEMI), non-ST elevation acute coronary syndrome …
elevation myocardial infarction (STEMI), non-ST elevation acute coronary syndrome …